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Bone infection remains a formidable challenge to themedical field.The goal of the current study is to evaluate antibacterial coatings
in vitro and to develop a large animalmodel to assess coated bone implants. Anovel coating consisting of titaniumoxide and siloxane
polymer doped with silver was created by metal-organic methods.The coating was tested in vitro using rapid screening techniques
to determine compositions which inhibited Staphylococcus aureus growth, while not affecting osteoblast viability. The coating was
then applied to intramedullary nails and evaluated in vivo in a caprinemodel. In this pilot study, a fracture was created in the tibia of
the goat, and Staphylococcus aureus was inoculated directly into the bone canal. The fractures were fixed by either coated (treated)
or non-coated intramedullary nails (control) for 5 weeks. Clinical observations as well as microbiology, mechanical, radiology, and
histology testing were used to compare the animals. The treated goat was able to walk using all four limbs after 5 weeks, while the
control was unwilling to bear weight on the fixed leg. These results suggest the antimicrobial potential of the hybrid coating and
the feasibility of the goat model for antimicrobial coated intramedullary implant evaluation.
1. Introduction
Stabilization of traumatic injuries by intramedullary nailing
is a very commonly used technique for the treatment of
long bone fractures. However, fracture repair and healing
may be complicated by the presence of open wounds, severe
soft-tissue injury, and environmental contamination. These
increase the potential for deepwound infection/osteomyelitis
and the development of delayed union/nonunion [1–13].
While titanium and stainless steel implants have been
the standard for fracture fixation, neither material provides
active resistance to bacterial infection nor prevents biofilm
formation [14].
Several types of surface treatments to reduce bacterial
growth and infection have been investigated, including the
introduction of nanosurface topography, manipulation of
surface chemistry, and the permanent attachment of antibi-
otic drugs to implants to inhibit bacterial attachment, growth
and resulting biofilm formation. Nanosurface modifications
are well developed and have been demonstrated to facilitate
healing and reduce the growth of bacteria, but not at the
log scale level [15]. Antoci et al. developed methods for
permanently attaching antibiotic drugs to medical devices
with good in vitro results against bacteria [16], but raise the
concern of preferentially selecting and encouraging develop-
ment of drug-resistant bacterial infections.
Silver has been used as an antibacterial material since
ancient time. Currently, it is used for burn wound treatment,
dental work, catheters, and bacterial infection control, in the
form of metallic silver, silver nitrate, and silver sulfadiazine.
Due to the recent increased number of antibiotic-resistant
bacteria, silver has been studied extensively as an alternative
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for antibiotics. Bactericidal effects of silver depend greatly
on concentration [17–19], particle size [20], and shape [21]
in the case of silver particles. Exposure to silver causes
changes in bacteria cell membrane morphology and damage
to intracellular proteins such as DNA, which affect cell
metabolism, cell division, and can result in cell death [20].
Recently, Jarrell et al. used titanium siloxane hybrid to
control the release of vanadium for soft-tissue integration
[22]. In this study, we report dose-dependent responses
of bone forming cells (osteoblast) and bacteria (S. aureus)
to hybrid coatings doped with silver. The current study
also aims to create a large animal model for osteomyelitis
and the evaluation of antimicrobial coated intramedullary
nails utilizing a goat tibia osteotomy model. A goat model
was chosen because of larger intramedullary canals which
permits testing of human size fracture fixation devices such
as intramedullary nails.
2. Materials and Methods
2.1. In Vitro Experiments
2.1.1. Materials. Titanium oxide and polymer hybrid surface
treatment solutions (BioIntraface, North Kingstown, RI,
USA) are a patented technology synthesized using metal-
organic chemistry and doped with metal-organic precursors
to form silver oxide dispersions within the matrix [23].
2.1.2. Preparation of Coatings. Stock precursor solutions for
titanium oxide, siloxane, and silver were allowed to age
15min at room temperature and briefly shaken before use.
These stock solutions were added together in a separate glass
container using a pipette to make hybrid stock solutions of
specific compositions and briefly shaken before use. Stock
solutions were mixed for titanium-siloxane hybrids and
were subsequently doped with increasing amount of silver
neodecanoate. Tertiary coatings are reported as weight%
of silver in the coating. A series of solutions with silver
concentration ranging from 0 to 18.26wt% was prepared. A
solution consisting of 100% silver neodecanoate was used as
positive control.The surface treatments were applied directly
to the bottom of tissue-culture-treated polystyrene (PS)
96-well microplates (Corning, Lowell, MA, USA), air dried,
and heat treated on a hotplate to 95∘C for one hour.
2.1.3. Primary Osteoblast Proliferation Assays. For human cell
assays, primary osteoblasts were cultured in primary cell
culture medium (ScienCell Research Laboratories, Carlsbad,
CA, USA) until being nearly confluent. Cells were then
collected and seeded on hybrid coated 96-well plates at a
density of 5000 cells/well. Cells were then incubated in a
standard culturing condition (37∘C, 5% CO
2
).
Osteoblast proliferation and viability on surface treat-
ments was measured using standard colorimetric WST-1
assay (Roche Applied Science, Indianapolis, IN, USA). For
WST-1 assay, after 2 days of incubation, each well of the
microplate was filled with 10𝜇L of WST-1 reagent. The
microplate was incubated at 37∘C, 5% CO
2
for an additional
4 hours. After the indicated time, the optical densitywasmea-
sured at 450 nm using a microplate reader (SpectraMax Plus
384 Spectrophotometer, Molecular Devices, Sunnyvale, CA,
USA). Measured absorbance was subtracted to absorbance of
the same well without cells and normalized to optical density
of polystyrene control.
2.1.4. Bacteria Adhesion and Grow Assays. For the bacterial
adhesion and growth assays, S. aureus (ATCC 25923, Man-
assas, VA, USA) was propagated in 5mL Luria Broth (LB,
Sigma, St. Louis, MO, USA) overnight and aliquot into 2mL
vials with 10% glycerol in fresh LB and kept at −80∘C. Two
days before experiments, bacteriawere streaked froma frozen
vial onto a LB agar plate and incubated at 37∘C for 1 day. A
single colony of S. aureuswas selected from the agar plate and
propagated in LB overnight to reach an optical density of 1.11
at 578 nm which corresponds to 2 × 1011 CFUs/mL. Bacteria
were diluted 1000 times using fresh LB and seeded onto the
hybrid surface treatments on microplate wells and incubated
for 20 minutes. The wells were then rinsed with 200𝜇L PBS
to remove nonadhered bacteria. 100 𝜇L fresh LB was added
to each well and incubated at 37∘C. After 1-day incubation,
optical density of each well at 578 nm was measured using a
microplate reader to determine bacteria growth.
For each experiment, at least six replicates were used for
each coating concentration. Statistical analysis was done by
Student’s t-test and data are expressed as mean ± standard
deviation (SD).
2.2. In Vivo Goat Model
2.2.1. Intramedullary Nail Coating. On preparation for a
large animal study, the surface treatment was dip-coated
onto 316LVM stainless steel intramedullary nails, 8mm ×
200mm (Surgical Implant GenerationNetwork (SIGN)).The
nails were withdrawn from the solution and air-dried at
room temperature before being packaged and autoclaved for
implantation.The interlocking screws were also coated using
the same technology. One unused coated screw and one
coated screw retrieved following the actual experiment were
analyzed using X-ray photoelectron spectrometer (XPS) to
confirm the presence of silver (Ag) on the surface before and
after the experiments.
2.2.2. Animal Selection. The study was approved by the
Brown University Institutional Animal Care and Use Com-
mittee (IACUC). Two mature female goats (1 control and 1
treatment), with a weight range of approximately 40–50 kg,
were used for this study.
2.2.3. Surgical Procedure. Radiographs of each operative tibia
were obtained immediately prior to surgery. After surgical
draping, the tibia was exposed through a 2 cm incision
over the medial aspect of the stifle and tibia. No systemic
antibiotics were given preoperatively or postoperatively. A
simulated open tibial fracture was created in the mid-
diaphysis with a sagittal saw cooled by saline irrigation.
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Standardized suspensions of S. aureus (ATCC 25923)
were diluted in phosphate buffer saline (PBS) to a final
inoculum concentration of 2 × 104 colony forming units per
milliliter (CFU/mL). Bacterial colony counts were confirmed
by culture using a spread-plate technique, in duplicate,
on tryptic soy agar. One milliliter of bacterial inoculum
was injected into the medullary canal at the osteotomy
site.
The osteotomy was then stabilized by internal fixation
using the stainless steel alloy intramedullary nail with prox-
imal and distal interlocking screws. The 8mm nail was
inserted after themedullary canal had been reamed to cortical
bone with flexible intramedullary reamers. Reaming was
carried out in 0.5mm increments to 9.5mm. Final insertion
of interlocking screws was then performed using the jig for
the SIGN nail system.The infrapatellar incision was irrigated
with normal saline solution and closed in layers with 3–0
Vicryl sutures (polyglycolic acid; Ethicon).
2.2.4. Postoperative Care. Postoperative pain management
included application of a fentanyl patch to the neck of each
goat. Examination of the goats by the veterinary staff was
performed prior to the removal of the patches.
The incision sites from the osteotomy were evaluated
weekly for inflammation. At each inspection, the condition of
the wound sites was photographed. Two 10mL vials of blood
(20mL total) were drawn from peripheral vessels under
sedation and tested for bacteria, complete blood count and
elemental analysis pre- and postoperatively, at weeks 1, 2, 4,
and prior to sacrifice. The silver and titanium levels were
measured in the whole blood by Inductively Coupled Plasma
(ICP) spectrometry at the time of sacrifice.
2.2.5. Samples Collection. At five weeks, the animals were
sacrificed by a lethal overdose of barbiturate (Beuthanasia-
D). Seven organs, including liver, heart, spleen, brain, kidney,
gallbladder, and small intestine, were collected and preserved
in 10% formalin solutions. The organ samples were then
shipped to Brooks Rand Labs (Seattle, WA, USA) for sil-
ver and titanium levels analysis using Inductively Coupled
Plasma mass spectrometry (ICP-MS) technique.
The hind limbs were harvested and preserved in 70%
ethanol solutions for further mechanical tests and histology.
2.2.6. Radiographic Evaluation. Craniocaudal (anteroposte-
rior) and lateromedial radiographs of the tibia were taken
preoperatively, immediately post-operative, and at postop-
eratively intervals at weeks 1, 2, 4, and 5 using general
anesthesia. The radiographs were coded and evaluated in a
blinded fashion by an experienced orthopaedic radiologist
not affiliated with the study, who graded the callous forma-
tion, the stability of the bone, alignment, and appearance of
fixation.
2.2.7. Mechanical Tests. The implanted nail was removed
from each harvested tibia utilizing an MTS 810 Servo
hydraulic Load Frame augmented with custom fixtures. Load
and displacement data were acquired using MTS flex test
software (Minneapolis, MN, USA) at 200Hz. Each specimen
was pulled at a displacement rate of 4mm/sec. The data were
reported as ultimate load, displacement at ultimate load, and
stiffness.
2.2.8. Microfocal Computed Tomography (Micro-CT) Tech-
nique. After the IM nails were explanted, the tibias were
cut down to 70mm in length, and cross-sectional images
were obtained using a computed tomography (CT) scanner
(𝜇CT 40, Scanco Medical, Bru¨ttisellen, Switzerland). During
scanning, the bones were oriented in the scanner such that
their sagittal, frontal, and transverse planes were aligned
with the scanner’s built-in coordinate system. Images were
acquired using machine settings of 70 kV and 114𝜇A. The
resolution of the scanned images was 36 𝜇m (isometric voxel
size). Three-dimensional images were reconstructed using
ImageJ software (NIH).
2.2.9. Histology. For histology, longitudinal sections of the
tibia were taken from the fracture site, preserved in 70%
ethanol, and prepared by methyl methacrylate processing
and embedding and hard tissue sectioning. Sections were
stained with hematoxylin and eosin (H&E), Toluidine Blue,
and Gram stain. Samples were evaluated by a board-certified
veterinary pathologist, who was blinded to the treatment and
control animals.
A semiquantitative grading scheme was implemented to
evaluate the extent of fracture healing, amount of bone lysis
and bone necrosis, degree of inflammation, and presence
of bacteria for both cortices. Individual scores obtained for
each cortex were then added and divided by two to obtain
an average score incorporating scores given for both cor-
tices. Components of the bone assessed for fracture healing
comprised the periosteal callus, osteotomy site, and cortical
bone adjacent to the osteotomy site. The grading scheme is
presented in Table 1, with the highest potential numerical
score for each cortex were 65.
2.2.10. Confocal Microscopy. Biofilm formation on the nail
was assessed by confocal microscopy. After mechanical
pullout testing, the nails were preserved in 70% ethanol
solution. The tip of the nail was cut using a bolt cutter
and placed in PBS. The nail tip was subsequently rinsed
three times with PBS to remove unattached tissues on nail
surface and transferred into a new vial containing 5mL of
4󸀠,6-diamidino-2-phenylindole (DAPI) 1mg/mL solution
(Invitrogen, Carlsbad, CA, USA) and FITC-conjugated S.
aureus antibody solution (Thermo Scientific). After contain-
ment for 15minutes at room temperature without exposure to
light, the sample was rinsed three times with PBS to remove
excessDAPI and antibody and imaged using aConfocal Laser
ScanningMicroscope (Zeiss LSM 510). Ten random 450 𝜇m×
450 𝜇m images on the nail surface were obtained. Due to the
curvature of the nail, confocal microscopy was preferable to
conventional fluorescent microscopy. The obtained fluores-
cent images were analyzed using ImageJ software for FITC
and DAPI surface coverage.
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Table 1: Histology scoring criteria.
Periosteal callus
Subjective size and quality Minimal/mild = 3; prominent, well organized = 2; prominentdisorganized = 1; incomplete union = 0
Woven-lamellar bone percent 0–25% = 3; 25–50% = 2; 50–75% = 1; 75–100% = 0
Cartilage tissue percent 0–25% = 3; 25–50% = 2; 50–75% or incomplete union = 1; 75–100% orfibrous nonunion = 0
Fibrovascular tissue percent 0–25% = 3; 25–50% = 2; 50–75% = 1; 75–100% or fibrous nonunion = 0
Inflammation percent 0–25% = 3; 25–50% = 2; 50–75% = 1; 75–100% = 0
Osteotomy site
Bridging bony callus percent 75–100% = 4; 50–75% = 3; 25–50% = 2; 10–25% = 1; 0–10 = 0
Woven-lamellar bone percent 0–25% = 3; 25–50% = 2; 50–75% = 1; 75–100% = 0
Mineralized bone percent 75–100% = 3; 50–75% = 2; 25–50% = 1; 0–25% = 0
Fibrovascular tissue percent 0–25% = 3; 25–50% = 2; 50–75% = 1; 75–100% or inflammatoryexudate = 0
Inflammation percent 0–25% = 3; 25–50% = 2; 50–75% = 1; 75–100% = 0
Adjacent cortical bone
Degree of osteolysis
None/minimal = 4; mild local expansion (remodeling) of osteonal
canals = 3; <1mm adjacent osteolysis = 2; 1–3mm adjacent osteolysis
= 1; >3mm adjacent osteolysis = 0
Extent of bone necrosis Empty lacunae and/or necrotic osteons: <2.5mm = 4; 2.5–5mm = 3;6mm–10mm = 2; 11–20mm = 1; >20mm = 0
Extent of inflammation
None/minimal = 4; mild local ostonal canals inflammation = 3;
inflammation >1mm distance = 2; 1–3mm distance = 1; >3mm
distance = 0
Presence of sequestra, for example, necrotic fragments of bone None = 8; 1–3 small <2mm = 4; >3 or single large >2mm = 2; singleto multiple large >5mm = 0
Presence of bacteria None = 8; rare small colonies = 4; multifocal colonies (<25𝜇m) = 2;multifocal large colonies (>50𝜇m) = 0
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Figure 1: Osteoblast proliferation on the coating as a function of
silver concentration by weight percent. The results are normalized
to the noncoated polystyrene (PS) controls. Data = Mean ± SD.
3. Results
3.1. Osteoblast and S. aureus Response to Silver-Doped
Ti/Siloxane Coating In Vitro. Osteoblast viability and pro-
liferation experiments were performed after two days of
incubation with several concentrations of silver oxide in the
coating.The results showed no reduction in cell proliferation
for up to 11.36% silver doping of the coating (Figure 1). Cell
density was lower on the substrates with 18.26% and 100%
silver.
Bacteria adhesion data showed that S. aureus growth was
completely eliminated in the presence of 1.8% or more of
silver in the coatings (Figure 2). A slightly increased optical
density on samples with more than 1.8% silver was due to the
elution of silver into the solution. The same plate with media
but no bacteria was used to confirm this trend (data not
shown). These results confirmed the antibacterial properties
of the silver doped hybrid coatings. Moreover, there is a
concentration window between 1.8% and 11.36% of silver in
which the coatings do not affect osteoblast growth while still
exhibiting bactericidal effects.
3.2. In Vivo Goat Model
3.2.1. Nail and Screw Coating and Characterization. The XPS
elemental analysis confirmed the presence of Ti andAg on the
coated sample (Figure 3). After explantation, the intensity of
Ag peak on the surface decreased. The results indicated that
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Figure 2: Staphylococcus aureus viability/proliferation on hybrid
surface treatments after one day, as a function of sliver concentration
by weight percent. The results are normalized to the noncoated
polystyrene (PS) controls. Data = Mean ± SD.
silver was released from the coating. However, not all silver
was released after 5 weeks of implantation.
3.2.2. Clinical Observations. The fractures on treated and
control goats were repaired successfully using IM nails
without further complications.The fentanyl patch, which was
used as pain reliever immediately after the operation, was
removed from the treated goat two days after surgery; the
patch on the control goatwas removed oneweek after surgery.
After 5 weeks of implantation, the treated goat lost 7%
of its initial body weight but was able to ambulate on the
tested limb. In contrast, the control goat lost 8.4% of its
weight and hesitated to bear weight on the tested limb,
holding the limb in a flexed position high when ambulating.
Subjective assessments regarding mentation, appetite, and
general activity were more positive for the treated goat than
the control goat.
3.2.3. Microbiology Evaluation. Bacterial cultures from the
proximal and distal screws collected after explantation were
positive for S. aureus on the screws taken from both control
and treated goat.
Throughout the study, blood samples were collected from
both animals for aerobic culture. At all time points, 0, 1, 2, 4,
and 5weeks post-op, blood culture showed no aerobic growth
in either goat (Table 2).
3.2.4. Complete Blood Count. Complete blood counts of the
control and treated goats are presented in Table 3. The white
blood cell count (WBC) of the control goat did not change
much after surgery.TheWBC of the treated goat varied more
but still in the normal range for goat (4–13 thousand/𝜇L).
The neutrophil percentage of the control goat increased
151% 1 week after surgery. This neutrophil level was in high
range until it eventually dropped in week 5. In contrast, the
neutrophil level of the treated goat did not change much
after surgery. The neutrophil level of treated goat also saw
a decrease at week 5. The lymphocyte percentage followed
the opposite trends compared to the neutrophil percentage
in both animals. The normal ranges for neutrophil and
lymphocyte in goats are 30–48% and 50–70%, respectively.
3.2.5. Radiographs. X-ray and micro-CT images of goats
tibias are shown in Figures 4 and 5, respectively. X-ray images
demonstrate goats tibias post-op and before sacrifice. For
each time point, anteroposterior (AP) and lateral (L) views
were provided. According to these images, both goats were
successfully stabilized using IM nails. There were no signs
of implant loosening after 5 weeks. Periosteal reactions and
infection were observed in both animals. The micro-CT
images showed clear sign of bone lysis and necrosis due to
bacterial infection.
Using the criteria shown in Table 4, the radiographs of
goats tibias at 5 weeks were assessed. There was little radio-
graphic difference between the control and the treated goats.
The osteotomies were not healed. Periosteal reaction and
osteolysis were observed, but without signs of sequestrum
and implant loosening in either goat.
3.2.6. Mechanical Testing. The mechanical testing results are
presented in Table 5. The ultimate load for the treated goat
was much higher than the value of the control goat. Testing
also showed that the coated nail was more difficult to remove
from its respective tibia than the noncoated nail, possibly
indicating more bacterial infection in control goat or higher
osseointegration in the treated goat.
3.2.7. Histology. Histological scores are presented in Table 6,
and representative photomicrographs of bone from each
animal are presented in Figure 6.Multifocal bacteria colonies
were observed within both treated and untreated goats;
however, average and individual scores for the tibial cortices
of the treated goat (4820) were higher than the scores for
the control goat (4818). Large areas of necrotic bone were
observed far from the osteotomy site (>20mm distance) in
both cortices of the control goat compared to one cortex of
the treated goat, and inflammation involving the adjacent
cortical bone was more severe in the control than treated
goat. Both animals had prominent, disorganized periosteal
callus and incomplete bony union with a large component
of fibrovascular connective tissue. Neither animal formed a
bridging callus that filled the osteotomy gap. Bony sequestra
were few (1–3) and small (<2mm diameter) for both animals.
Using the histology criteria in Table 5, the average score of the
treated goat (4820) was 16.5 points, slightly higher than that
of the control goat (4818), 10 points.
3.2.8. Silver Level in Goat Organs and Blood. The silver levels
in all organs harvested from the control goat (4818) were
lower than the method detection limits of the measurements.
Silver level in liver of the treated goat (4820) was detected to
be 0.045 ppm, which was higher than the method detection
limit (0.02 ppm) but still lower than the method reporting
limit (0.099 ppm). No silver was detected from other organs
of the treated goat. The results indicated that some silver was
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Figure 3: XPS analysis of coated interlocking screw. Silver was present on both unused (a) and used (b) screws. The analysis also confirmed
the existence of Ti on the coated surface.
Table 2: Bacteria culture results from distal and proximal screw sites, fracture site, and blood.
Goats number Distal screw site Proximal screw site Fracture site Blood
4818 (control) +++ +++ +++ −NEGS. aureus S. aureus (2 biotypes) S. aureus (2 biotypes)
4820 (treated) ++ ++++ + −NEG
S. aureus (2 biotypes) S. aureus S. aureus
released from the coating into the goat body, but the silver
level was very low.
No silver or titanium was detected in any goat serum
samples.
3.2.9. Confocal Microscope Images. Fluorescent labeling
was performed using DAPI nucleus staining and FITC-
conjugated S. aureus antibodies. Representative images are
presented in Figure 7, in which two fluorescent channels
(blue: DAPI; green: FITC) were utilized. Biofilm was clearly
differentiated from any native animal tissue that grew on the
surface of the IM nail.
Surface coverage for DAPI and FITCwas calculated using
ImageJ software. Average coverage per a 450 𝜇m × 450 𝜇m
area on IM nail surface is shown in Figure 8. Not many
colonies of bacteria were found on surface of both control
and treated nails. The treated surface had slightly more
DAPI and FITC coverage. However, since the number of
colonieswas low anddistributed nonhomogenously, the error
of the measurement was high and the differences were not
statistically significant.
4. Discussion
In this study, a nondrug antibacterial coating using silver-
doped metal oxide/polymer hybrid was assessed. The mate-
rials were first coated onto a 96-well plate for in vitro
assessment. As expected, there was a dose-dependent trend
of antibacterial effect of the coating. With higher than 1.8%
silver in the coating, S. aureus proliferation was reduced
significantly compared to the control. It is also important
to note that cell proliferation experiments were performed
with the same materials using primary osteoblasts. The
results showed that reduced cell proliferationwas observed in
coatings with 11.36% and higher amount of silver. Therefore,
a coating with silver concentration in the window ranging
from 1.8% to 11.36% will be effective for inhibiting S. aureus
proliferation without reducing osteoblast growth in vitro.
In the current study, the technology was transferred from
in vitro to in vivo. The antibacterial coating was tested using
a goat osteotomy model. To our knowledge, this is the first
study of its kind to look at antibacterial coated IM nails in
a large animal model. Recently, Schaer et al. and Stewart
et al. performed a similar, important study on antibiotic
coated plates in a sheep model [24, 25]. However, we believe
that developing an IM nail model is crucial because of the
popularity of IM nails used in human trauma cases.
In this study, the simulated tibia fracture was induced and
S. aureus was used to cause infection. After 5 weeks, both
goats showed signs of infection as supported by lameness,
reduced body weight, differential WBC counts, diagnostic
imaging, and histopathologic findings. Aspirate from both
the screw sites and the fracture sites showed microorganisms
and were confirmed to be S. aureus. Therefore, the amount
of bacteria used in this study (2 × 104 cfu) was enough
to generate infection in goat tibia. In fact, further study
should consider using fewer bacteria and a better inoculate
technique. Infection in soft tissue reduced the effectiveness
of the coating and resulted in nonreliable quantitative data.
The mechanical pullout testing experiments showed
higher ultimate load to remove the treated nail compared
to the control nail. These data could imply that the control
goat had a more severe infection inside the medullary canal,
which resulted in loosening around the nail. Alternatively, it
might suggest that the treated goat had more bone in-growth
onto the surface of the nail [26]. Combining radiographic,
CT imaging, histology data, and the short duration of the
study, amore severe infection in control goat is themore likely
explanation. It is also possible that canal shape and curvature
mismatch of the nail were responsible for different pullout
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Table 3: Complete blood count showing white blood cell count (WBC), neutrophil percentage, and lymphocyte percentage at preoperation
and weeks 1, 2, 4, and 5.
Time 4818 (control) 4820 (treated)
WBC (Thous./𝜇L) Neutrophil (%) Lymphocyte (%) WBC (Thous./𝜇L) Neutrophil (%) Lymphocyte (%)
Pre-op 6.3 31 64 9.7 74 21
Week 1 6.2 78 22 6.2 61 38
Week 2 5.9 67 33 7.9 73 26
Week 4 6.4 79 21 6.3 76 24
Week 5 5.6 37 55 8.8 59 39
4818 AP-post 4818 L-post 4818 AP-WK5 4818 L-WK5 
4820 AP-post 4820 L-post 4820 AP-WK5 4820 L-WK5 
Figure 4: X-ray radiographs of the control (4818) and treated (4820) goat tibias immediately after surgery and 5 weeks after surgery. At each
time point, craniocaudal (anteroposterior) and lateromedial views were taken. All images are at the same scale.
strengths. Nevertheless, to obtain a more conclusive result, a
larger population of samples would be desirable.
In our current study, silver was released in ionic form
instead of nanoparticles.Many studies on silver nanoparticles
have shown bactericidal effect on several different bacteria
species [19, 21, 27, 28]. However, concerns have been raised
regarding adverse effects when nanomaterials penetrate and
interact with host cells [29–31]. The amount of silver released
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Figure 5:Micro-CT images of the tibia after the nails were removed. Images were taken at osteotomy sites and reconstructed using ImageJ. 3D
reconstruction, top view and side view images for 4818 control goats ((a), (b), and (c)) and 4820 treated goats ((d), (e), and (f)) are presented.
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Figure 6: Composite photomicrographs of H&E stained longitudinal sections from the tibias cortex of control goat (4818) (a) and treated
goat (4820) (b). 2X magnification photomicrographs (scale bars = 1mm) show large periosteal callus (a,b—vertical double-headed arrows)
composed of woven bone and fibrous connective tissue surrounding the osteotomy sites, which are not bridged by callus (a,b—horizontal
double-headed arrows). Lysis of adjacent cortical bone (a,b—C) is evident, and inflammation (a,b—asterisks) concentrated at the osteotomy
site dissects through the cortex of 4818. Folds in the cortex of 4820 (b, white arrows) are artifacts of processing. 20X magnification
photomicrographs (insets, scale bars = 50 𝜇m) show necrotic debris (a, inset—asterisk) surrounded by inflammation (a, inset—i) and
microsequestra (a, inset—arrow). A large bacteria colony surrounded by radiating arrays of proteinaceous material (b, inset—asterisk),
consistent with Splendore-Hoeppli formation is surrounded by inflammation (b, inset—i).
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Figure 7: Representative confocal images of biofilm and tissue formed on an IMnail surface. Blue channel (a) and green channel (b) represent
DAPI nucleus staining and FITC conjugated S. aureus antibodies. (c) and (d) are overlay images of both channels with 3D projection on 𝑥
(d1) and 𝑦 (d2) axes.
Table 4: Assessments from radiographs of treated and control goat
tibias. The criteria here are bridging callus, periosteal reaction,
osteolysis, sequestrum, implant loosening, and soft-tissue swelling.
Radiology criteria 4818 (control) 4820 (treated)
Bridging callus <50% (1/4 cortices) <50% (1/4 cortices)
Periosteal reaction Present Minimal
Osteolysis
Present (irregular
osteolysis
proximally)
Minimal
Sequestrum Absent Absent
Implant loosening Absent Absent
Soft-tissue swelling Not evaluable Not evaluable
into the goats’ blood and organs after 5weeks in our studywas
negligible. Hence, a cytotoxic effect caused by the systemic
release of silver is minimal or less likely.
A histology grading scheme was developed in this study.
Using this detailed scoring system, both cortices of the
control and the treated goat were evaluated. The treated
goat received a higher score and exhibited less inflammation.
Table 5: Mechanical testing results showed ultimate load and
displacement to remove the intramedullary nail from goats, tibias
after 5 weeks of implantation.
Mechanical testing
criteria 4818 (control) 4820 (treated)
Ultimate load (N) 150.3 497.6
Displacement (mm) 8.7 2.7
However, a larger set of animals is needed to confirm any
statistically significant difference of the treatment.
In order to visualize the nail surface after removal from
the goat tibia, confocal microscopy was utilized. Using this
method, surface coverage of bacteria biofilm and tissue
was quantified using image analysis. Both cells and bacte-
ria were observed on control and treated nails. However,
the differences in surface coverage were not statistically
significant. More images can be obtained to improve the
comparison.Thismethod could also provide a 3-dimensional
reconstruction of biofilm presented on nail surface, which
can be further quantified using image analysis tool.
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Table 6: Histology scores for control goat (4818) and treated goat (4820) assessed for callus formation, osteotomy site, adjacent cortical bone,
presence of sequestra, and bacterial persistence. Averages of the added scores from each cortex are given. Highest potential score is 65.
Histology criteria Cortex 1 (4818) Cortex 2 (4818) Cortex 1 (4820) Cortex 2 (4820)
Periosteal callus formation
Subjective size and quality 1 1 1 0
Woven-lamellar bone 0 0 0 0
Cartilage (hyaline and fibrocartilage) 1 0 3 0
Fibrovascular tissue 2 0 3 0
Inflammation 3 1 3 2
Osteotomy site
Bridging bony callus 0 0 0 0
Woven-lamellar bone 0 0 0 0
Mineralized bone 0 0 0 0
Fibrovascular tissue 0 0 0 0
Inflammation 2 0 0 0
Adjacent cortical bone
Osteolysis 0 1 1 0
Osteon/osteocyte necrosis 0 0 4 1
Inflammation 0 0 1 4
Sequestra 4 4 4 4
Bacterial persistence 0 0 0 2
Total 13 7 20 13
Average 10 16.5
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Figure 8: DAPI and FITC surface coverage on IM nails explanted
from treated goat (4820) and control goat (4818). The surface
coverage for DAPI (dark grey) is higher and is expressed using the
left y-axis.The surface coverage for FITC (light grey) is showed using
the right y-axis. Data = Mean ± SEM. Averages were taken from 10
random 450 𝜇m × 450 𝜇m images.
5. Conclusion
In the current study, a caprine model was developed to
study osteomyelitis and infection resistant IM nails. Grading
systems and analysis methods were established to evaluate
a novel hybrid coating. The goat that received a coated IM
nail was more healthy and able to walk better after 5 weeks
of treatment. The treated goat also received better histology
score. However, only two goats were used to create this
model. A larger set of animals with adjusted inoculation
amount and methodology will likely improve the statistical
differences between the treatments. Amethod using confocal
microscopy and fluorescent labeling was also presented to
quantify biofilm formation on IM nail surfaces. With an
increasing number of antibiotic resistant bacteria, alternative
coatings (such as silver) for orthopaedic medical devices are
needed. We hope that the model developed in this study will
be useful for evaluating such coatings in a preclinical setting.
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